Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned
David Weise, Tobias Warnecke, Carsten Buhmann, Georg Ebersbach, Carsten Eggers, Björn Falkenburger, Günter Höglinger, Brit Mollenhauer, David Pedrosa, Martin Südmeyer, Daniel Weiss, Jan Kassubek, Wolfgang H. Jost · 2026
Read Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned by David Weise, Tobias Warnecke, Carsten Buhmann, Georg Ebersbach, Carsten Eggers, Björn Falkenburger, Günter Höglinger, Brit Mollenhauer, David Pedrosa, Martin Südmeyer, Daniel Weiss, Jan Kassubek, Wolfgang H. Jost (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13531757.txt.
Description
David Weise and co-authors published a review in 2026 on real-world use in Germany of a skin-pump therapy for advanced Parkinson disease. The therapy delivers two drug precursors under the skin around the clock. Two years after approval, much practice experience had gathered. The authors distill practical advice for clinicians.
Topics include picking suitable patients, starting doses, and balancing the pump with oral drugs. Skin reactions at the infusion site are common but manageable, and mental health risks in older or impaired patients need care. Reasons for stopping and office organization are covered. Early dropout rates fell as experience grew, and the authors advise adjusting oral drugs carefully over chasing single-drug therapy.
Catalog record
| CREATOR | David Weise, Tobias Warnecke, Carsten Buhmann, Georg Ebersbach, Carsten Eggers, Björn Falkenburger, Günter Höglinger, Brit Mollenhauer, David Pedrosa, Martin Südmeyer, Daniel Weiss, Jan Kassubek, Wolfgang H. Jost |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |